Publications - Scientific Articles - Conferences presentations
PUBLICATIONS
(selection, for full list see Pubmed)
- Flahault A, Calmy A, Costagliola D, Drapkina O, Eckerle I, Larson HJ, Legido-Quigley H, Noakes C, Kazatchkine M, Kluge H. No time for complacency on COVID-19 in Europe. Lancet. 2023 May 22;401(10392):1909–12.
- Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 2023 Mar;21(3):147-161.
- Keusch GT, Amuasi JH, Anderson DE, Daszak P, Eckerle I, Field H, Koopmans M, Lam SK, Das Neves CG, Peiris M, Perlman S, Wacharapluesadee S, Yadana S, Saif L. Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses. Proc Natl Acad Sci U S A. 2022 Oct 18;119(42):e2202871119.
- Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A, Jacquérioz F, Kaiser L, Vetter P, Eckerle I, Meyer B. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022 Jul;28(7):1491-1500.
- Bekliz M, Adea K, Vetter P, Eberhardt CS, Hosszu-Fellous K, Vu DL, Puhach O, Essaidi-Laziosi M, Waldvogel-Abramowski S, Stephan C, L'Huillier AG, Siegrist CA, Didierlaurent AM, Kaiser L, Meyer B, Eckerle I. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs. Nat Commun. 2022 Jul 4;13(1):3840.
- Vetter P, Jacquérioz F, Eckerle I. Different virus, same mistakes: Why (re-) emerging viruses are one step ahead of us. Innovation (Camb). 2022 Jun 23;3(4):100273.
- Lorthe E, Bellon M, Berthelot J, Michielin G, L'Huillier AG, Posfay-Barbe KM, Azman AS, Guessous I, Maerkl SJ, Eckerle I, Stringhini S; SEROCoV-Schools Study Group. A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland. Lancet Infect Dis. 2022 Jun;22(6):767-768.
- A prospective longitudinal study: Lorthe E, Bellon M, Michielin G, Berthelot J, Zaballa ME, Pennacchio F, Bekliz M, Laubscher F, Arefi F, Perez-Saez J, Azman AS, L'Huillier AG, Posfay-Barbe KM, Kaiser L, Guessous I, Maerkl SJ, Eckerle I, Stringhini S; SEROCoV-Schools Study Group. Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school. PLoS One. 2022 Aug 17;17(8).
- Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant. Bekliz M, Adea K, Puhach O, Perez-Rodriguez F, Marques Melancia S, Baggio S, Corvaglia AR, Jacquerioz F, Alvarez C, Essaidi-Laziosi M, Escadafal C, Kaiser L, Eckerle I. Microbiol Spectr. 2022 Aug 31;10(4):e0085322.
- Ulrich L, Halwe NJ, Taddeo A, Ebert N, Schön J, Devisme C, Trüeb BS, Hoffmann B, Wider M, Fan X, Bekliz M, Essaidi-Laziosi M, Schmidt ML, Niemeyer D, Corman VM, Kraft A, Godel A, Laloli L, Kelly JN, Calderon BM, Breithaupt A, Wylezich C, Veiga IB, Gultom M, Osman S, Zhou B, Adea K, Meyer B, Eberhardt C, Thomann L, Gsell M, Labroussaa F, Jores J, Summerfield A, Drosten C, Eckerle I, Wentworth DE, Dijkman R, Hoffmann D, Thiel V, Beer M, Benarafa C. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta. Nature. 2021 Dec 22. doi: 10.1038/s41586-021-04342-0.
- Essaidi-Laziosi M, Perez Rodriguez FJ, Hulo N, Jacquerioz F, Kaiser L, Eckerle I. Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells. Lancet Microbe. 2021 Nov;2(11):e571. doi: 10.1016/S2666-5247(21)00216-0.
- Bekliz M, Adea K, Essaidi-Laziosi M, Sacks JA, Escadafal C, Kaiser L, Eckerle I. SARS-CoV-2 antigen-detecting rapid tests for the delta variant. Lancet Microbe. 2021 Nov 24. doi: 10.1016/S2666-5247(21)00302-5.
- Essaidi-Laziosi M, Alvarez C, Puhach O, Sattonnet-Roche P, Torriani G, Tapparel C, Kaiser L, Eckerle I. Emerg Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. Microbes Infect. 2021 Dec 21:1-26. doi: 10.1080/22221751.2021.2021806.
- Bekliz M, Adea K, Essaidi-Laziosi M, Sacks JA, Escadafal C, Kaiser L, Eckerle I. SARS-CoV-2 rapid diagnostic tests for emerging variants. Lancet Microbe. 2021 Aug;2(8):e351. doi: 10.1016/S2666-5247(21)00147-6.
- A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples. Swank Z, Michielin G, Yip HM, Cohen P, Andrey DO, Vuilleumier N, Kaiser L, Eckerle I, Meyer B, Maerkl SJ. PNAS. 2021.
- Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series. Vetter P, Eberhardt CS, Meyer B, Martinez Murillo PA, Torriani G, Pigny F, Lemeille S, Cordey S, Laubscher F, Vu DL, Calame A, Schibler M, Jacquerioz F, Blanchard-Rohner G, Siegrist CA, Kaiser L, Didierlaurent AM, Eckerle I. mSphere. 2020 Nov 11;5(6):e00827-20. doi: 10.1128/mSphere.00827-20.
- Scientific consensus on the COVID-19 pandemic: we need to act now. Alwan NA, Burgess RA, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman LR, Greenhalgh T, Gurdasani D, Hamdy A, Hanage WP, Hodcroft EB, Hyde Z, Kellam P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar D, Swanton C, Walensky RP, Yamey G, Ziauddeen H. Lancet. 2020 Oct 31;396(10260):e71-e72. doi: 10.1016/S0140-6736(20)32153-X.
- Baggio S, L'Huillier AG, Yerly S, Bellon M, Wagner N, Rohr M, Huttner A, Blanchard-Rohner G, Loevy N, Kaiser L, Jacquerioz F, Eckerle I. SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19. Clin Infect Dis. 2020 Aug 6:ciaa1157. doi: 10.1093/cid/ciaa1157.
- SARS-CoV-2 seroprevalence in COVID-19 hotspots. Eckerle I, Meyer B. Lancet. 2020 Aug 22;396(10250):514-515. doi: 10.1016/S0140-6736(20)31482-3.
- Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Zimmer G, Agoritsas T, Stirnemann J, Spechbach H, Guessous I, Stringhini S, Pugin J, Roux-Lombard P, Fontao L, Siegrist CA, Eckerle I, Vuilleumier N, Kaiser L; Geneva Center for Emerging Viral Diseases. Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 Oct;26(10):1386-1394. doi: 10.1016/j.cmi.2020.06.024.
- L'Huillier AG, Torriani G, Pigny F, Kaiser L, Eckerle I. Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents. Emerg Infect Dis. 2020 Oct;26(10):2494-2497. doi: 10.3201/eid2610.202403.
- Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0.
2022
SCIENTIFIC ARTICLES
- PUHACH, Olha, MEYER, Benjamin, ECKERLE, Isabella Anne. SARS-CoV-2 viral load and shedding kinetics. In: Nature reviews. Microbiology, 2022, vol. 21, n° 3, p. 147–161. doi: 10.1038/s41579-022-00822-w.
- BEKLIZ, Meriem et al. Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant. In: Microbiology spectrum, 2022, vol. 10, n° 4, p. e0085322. doi: 10.1128/spectrum.00853-22.
- LORTHE, Elsa et al. Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study. In: PloS one, 2022, vol. 17, n° 8, p. e0272663. doi: 10.1371/journal.pone.0272663.
- LORTHE, Elsa et al. A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland. In: The Lancet. Infectious diseases, 2022, vol. 22, n° 6, p. 767–768. doi: 10.1016/S1473-3099(22)00267-5.
- VETTER, Pauline, JACQUERIOZ, Frédérique Aline, ECKERLE, Isabella Anne. Different virus, same mistakes: Why (re-) emerging viruses are one step ahead of us. In: The Innovation, 2022, vol. 3, n° 4, p. 100273. doi: 10.1016/j.xinn.2022.100273.
- PUHACH, Olha et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. In: Nature medicine, 2022, vol. 28, n° 7, p. 1491–1500. doi: 10.1038/s41591-022-01816-0.
- BAGGIO, Stéphanie et al. Feasibility of home-based ELISA capillary blood self-testing for anti-SARS-CoV-2 antibodies. In: Practical laboratory medicine, 2022, vol. 31, p. e00290. doi: 10.1016/j.plabm.2022.e00290.
- BEKLIZ, Meriem et al. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs. In: Nature communications, 2022, vol. 13, n° 1, p. 3840. doi: 10.1038/s41467-022-31556-1.
- ESSAIDI-LAZIOSI, Manel et al. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. In: Emerging microbes & infections, 2022, vol. 11, n° 1, p. 412–423. doi: 10.1080/22221751.2021.2021806.
- BEKLIZ, Meriem et al. SARS-CoV-2 antigen-detecting rapid tests for the delta variant. In: The Lancet microbe, 2022, vol. 3, n° 2, p. e90. doi: 10.1016/S2666-5247(21)00302-5.
- ULRICH, Lorenz et al. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta. In: Nature, 2022, vol. 602, n° 7896, p. 307–313. doi: 10.1038/s41586-021-04342-0.
2021
SCIENTIFIC ARTICLES
- VU CANTERO, Diem-Lan et al. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms. In: Journal of clinical immunology, 2021, vol. 41, n° 8, p. 1723–1732. doi: 10.1007/s10875-021-01134-z.
- VONO, Maria et al. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. In: Cell reports, 2021, vol. 37, n° 1, p. 109773. doi: 10.1016/j.celrep.2021.109773
- BEKLIZ, Meriem et al. SARS-CoV-2 rapid diagnostic tests for emerging variants. In: The Lancet. Microbe, 2021, vol. 2, n° 8, p. e351. doi: 10.1016/S2666-5247(21)00147-6.
- BOEHM, Erik et al. Novel SARS-CoV-2 variants: the pandemics within the pandemic. In: Clinical Microbiology and Infection, 2021, vol. 27, n° 8, p. 1109–1117. doi: 10.1016/j.cmi.2021.05.022.
- CHEN, Chaoran et al. Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland. In: Epidemics, 2021, vol. 37, p. 100480. doi: 10.1016/j.epidem.2021.100480.
- BELLON, Mathilde Anne et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load kinetics in symptomatic children, adolescents, and adults. In: Clinical Infectious Diseases, 2021, vol. 73, n° 6, p. e1384–e1386. doi: 10.1093/cid/ciab396.
- ZIMMERLI, Aurelia et al. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery. In: Frontiers in Immunology, 2021, vol. 12. doi: 10.3389/fimmu.2021.613502.
- L’HUILLIER, Arnaud et al. Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting. In: Journal of Clinical Microbiology, 2021, vol. 59, n° 9, p. e0099121. doi: 10.1128/JCM.00991-21.
- BINDER, Florian et al. Inhibition of interferon I induction by non-structural protein NSs of Puumala virus and other vole-associated orthohantaviruses: phenotypic plasticity of the protein and potential functional domains. In: Archives of Virology, 2021, vol. 166, n° 11, p. 2999–3012. doi: 10.1007/s00705-021-05159-y.
- PIGNY, Fiona et al. Viral co-infections among SARS-CoV-2-infected children and infected adult household contacts. In: European Journal of Pediatrics, 2021, vol. 180, n° 6, p. 1991–1995. doi: 10.1007/s00431-021-03947-x
- KEISER, Olivia et al. A public health strategy for SARS-CoV-2, grounded in science, should guide Swiss schools through the coming winter. In: Swiss medical weekly, 2021, vol. 151, p. w30086. doi: 10.4414/SMW.2021.w30086.
- RICHARD, Aude et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study. In: Scandinavian journal of public health, 2021, p. 140349482110480. doi: 10.1177/14034948211048050.
- GONCALVES CABECINHAS, Ana Rita et al. SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of october 2020 to february 2021-implementation of swiss-wide diagnostic screening and whole genome sequencing. In: Microorganisms, 2021, vol. 9, n° 4. doi: 10.3390/microorganisms9040677
- VETTER, Pauline et al. Puumala Virus Infection in Family, Switzerland. In: Emerging Infectious Diseases, 2021, vol. 27, n° 2, p. 658–660. doi: 10.3201/eid2702.203770.
- L’HUILLIER, Arnaud, BAGGIO, Stéphanie, ECKERLE, Isabella Anne. Viral Loads of SARS-CoV-2 in Young Children. In: JAMA pediatrics, 2021, vol. 175, n° 5, p. 529–530. doi: 10.1001/jamapediatrics.2020.5548.
- BI, Qifang et al. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. In: Nature Communications, 2021, vol. 12, n° 1, p. 3643. doi: 10.1038/s41467-021-23733-5.
- PRIESEMANN, Viola et al. An action plan for pan-European defence against new SARS-CoV-2 variants. In: Lancet (British ed. Online), 2021, vol. 397, n° 10273, p. 469–470. doi: 10.1016/S0140-6736(21)00150-1.
- YAHAV, Dafna et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. In: Clinical microbiology and infection, 2021, vol. 27, n° 3, p. 315–318. doi: 10.1016/j.cmi.2020.11.028.
- IHLING, Clara Marlene et al. Molecular epidemiology of respiratory syncytial virus in children in sub-Saharan Africa. In: Tropical medicine & international health, 2021, vol. 26, n° 7, p. 810–822. doi: 10.1111/tmi.13573.
- YEBOAH, Richmond et al. Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana. In: One Health Outlook, 2021, vol. 3, n° 1, p. 13. doi: 10.1186/s42522-021-00043-w.
- PEREZ-SAEZ, Javier et al. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. In: Clinical Microbiology and Infection, 2021. doi: 10.1016/j.cmi.2021.06.040.
- SWANK, Zoe et al. A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples. In: Proceedings of the National Academy of Sciences, 2021, vol. 118, n° 18, p. e2025289118. doi: 10.1073/pnas.2025289118.
- MARTISCHANG, Romain et al. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort study. In: Infection Control and Hospital Epidemiology, 2021, p. 1–8. doi: 10.1017/ice.2021.117.
- L’HUILLIER, Arnaud et al. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study. In: Clinical Microbiology and Infection, 2021, vol. 27, n° 5, p. 784.e1–784.e8. doi: 10.1016/j.cmi.2021.01.005.
- NGO NSOGA, Marie Thérèse et al. Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2. In: PLOS ONE, 2021, vol. 16, n° 6, p. e0253321. doi: 10.1371/journal.pone.0253321.
- ESSAIDI, Manel et al. Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells. In: The Lancet. Microbe, 2021. doi: 10.1016/S2666-5247(21)00216-0.
- PAGANO, Sabrina et al. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. In: European Journal of Clinical Investigation, 2021, vol. 51, n° 11, p. e13661. doi: 10.1111/eci.13661.
- GRAZIOLI, Serge et al. Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19. In: Journal of the Pediatric Infectious Diseases Society, 2021, vol. 10, n° 6, p. 706–713. doi: 10.1093/jpids/piaa142.
- ANDREY, Diego Olivier et al. Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings. In: Journal of Clinical Medicine, 2021, vol. 10, n° 8, p. 1605. doi: 10.3390/jcm10081605.
- BERGER, Alice et al. Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers. In: PLOS ONE, 2021, vol. 16, n° 3, p. e0248921. doi: 10.1371/journal.pone.0248921.
- VETTER, Pauline et al. Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection. In: Clinical Microbiology and Infection, 2021. doi: 10.1016/j.cmi.2021.02.010.
2020
SCIENTIFIC ARTICLES
- STRANDIN, Tomas et al. Orthohantavirus Isolated in Reservoir Host Cells Displays Minimal Genetic Changes and Retains Wild-Type Infection Properties. In: Viruses, 2020, vol. 12, n° 4, p. 457. doi: 10.3390/v12040457.
- FLAHAULT, Antoine et al. Precision global health for real-time action. In: The Lancet. Digital health, 2020, vol. 2, n° 2, p. e58–e59. doi: 10.1016/S2589-7500(19)30240-7.
- MUENCH, Peter et al. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2. In: Journal of Clinical Microbiology, 2020, vol. 58, n° 10, p. e01694–20. doi: 10.1128/JCM.01694-20.
- MÖGLING, Ramona et al. Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination. In: Emerging Infectious Diseases, 2020, vol. 26, n° 8, p. 1944–1946. doi: 10.3201/eid2608.201843.
- SALATHÉ, Marcel et al. COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation. In: Swiss Medical Weekly, 2020, vol. 150, p. w20225. doi: 10.4414/smw.2020.20225.
- VETTER, Pauline, ECKERLE, Isabella Anne, KAISER, Laurent. Covid-19: a puzzle with many missing pieces. In: BMJ (Clinical Research Edition), 2020, vol. 368, p. m627. doi: 10.1136/bmj.m627.
- FERNANDES, José Francisco et al. Causes of fever in Gabonese children: a cross-sectional hospital-based study. In: Scientific Reports, 2020, vol. 10, n° 1, p. 2080. doi: 10.1038/s41598-020-58204-2.
- FERNANDES, José Francisco et al. Unbiased metagenomic next-generation sequencing of blood from hospitalized febrile children in Gabon. In: Emerging Microbes & Infections, 2020, vol. 9, n° 1, p. 1242–1244. doi: 10.1080/22221751.2020.1772015.
- L’HUILLIER, Arnaud et al. Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents. In: Emerging Infectious Diseases, 2020, vol. 26, n° 10, p. 2494–2497. doi: 10.3201/eid2610.202403.
- VETTER, Pauline et al. Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series. In: mSphere, 2020, vol. 5, n° 6, p. e00827–20. doi: 10.1128/mSphere.00827-20.
- ALWAN, Nisreen A et al. Scientific consensus on the COVID-19 pandemic: we need to act now. In: The Lancet, 2020, vol. 396, n° 10260, p. e71–e72. doi: 10.1016/S0140-6736(20)32153-X.
- MEYER, Benjamin et al. Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT). In: Emerging Microbes & Infections, 2020, vol. 9, n° 1, p. 2394–2403. doi: 10.1080/22221751.2020.1835448.
- BAGGIO, Stéphanie et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19). In: Clinical Infectious Diseases, 2020. doi: 10.1093/cid/ciaa1157.
- ANDREY, Diego Olivier et al. Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests. In: Journal of Clinical Medicine, 2020, vol. 9, n° 8, p. 2369. doi: 10.3390/jcm9082369.
- ANDREY, Diego Olivier et al. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. In: European Journal of Clinical Investigation, 2020, vol. 50, n° 10, p. e13357. doi: 10.1111/eci.13357.
- ECKERLE, Isabella Anne, MEYER, Benjamin. SARS-CoV-2 seroprevalence in COVID-19 hotspots. In: The Lancet, 2020, vol. 396, n° 10250, p. 514–515. doi: 10.1016/S0140-6736(20)31482-3.
- STRINGHINI, Silvia et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. In: The Lancet, 2020, vol. 396, n° 10247, p. 313–319. doi: 10.1016/S0140-6736(20)31304-0.
- MEYER, Benjamin et al. Validation of a commercially available SARS-CoV-2 serological immunoassay. In: Clinical Microbiology and Infection, 2020. doi: 10.1016/j.cmi.2020.06.024.
2019
SCIENTIFIC ARTICLES
- ROSSKOPF, Sascha P et al. Nycteria and polychromophilus parasite infections of bats in central Gabon. In: Infection, Genetics and Evolution, 2019, vol. 68, p. 30–34. doi: 10.1016/j.meegid.2018.11.022.
2018
SCIENTIFIC ARTICLES
- ECKERLE, Isabella Anne et al. Emerging souvenirs — clinical presentation of the returning traveller with imported arbovirus infections in Europe. In: Clinical microbiology and infection, 2018, vol. 24, n° 3, p. 240–245. doi: 10.1016/j.cmi.2018.01.007.
- REUSKEN, C B et al. Laboratory preparedness and response with a focus on arboviruses in Europe. In: Clinical microbiology and infection, 2018, vol. 24, n° 3, p. 221–228. doi: 10.1016/j.cmi.2017.12.010.
- SIGFRID, L et al. Preparing clinicians for (re-)emerging arbovirus infectious diseases in Europe. In: Clinical microbiology and infection, 2018, vol. 24, n° 3, p. 229–239. doi: 10.1016/j.cmi.2017.05.029.
- SLATER, Tessa, ECKERLE, Isabella Anne, CHANG, Kin-Chow. Bat lung epithelial cells show greater host species-specific innate resistance than MDCK cells to human and avian influenza viruses. In: Virology Journal, 2018, vol. 15, n° 1, p. 68. doi: 10.1186/s12985-018-0979-6.
- SIGFRID, L et al. Strengthening preparedness for (re-) emerging arboviruses in Europe. In: Clinical Microbiology and Infection, 2018, vol. 24, n° 3, p. 219–220. doi: 10.1016/j.cmi.2018.02.001.
- HOGAN, Benedikt et al. Malaria Coinfections in Febrile Pediatric Inpatients: A Hospital-Based Study From Ghana. In: Clinical Infectious Diseases, 2018, vol. 66, n° 12, p. 1838–1845. doi: 10.1093/cid/cix1120.
2017
SCIENTIFIC ARTICLES
- HELD, Jana et al. Bats are rare reservoirs of Staphylococcus aureus complex in Gabon. In: Infection, genetics and evolution, 2017, vol. 47, p. 118–120. doi: 10.1016/j.meegid.2016.11.022.
2016
SCIENTIFIC ARTICLES
- EHLEN, Lukas et al. Epithelial cell lines of the cotton rat (Sigmodon hispidus) are highly susceptible in vitro models to zoonotic Bunya-, Rhabdo-, and Flaviviruses. In: Virology journal, 2016, vol. 13, p. 74. doi: 10.1186/s12985-016-0531-5.
- CORMAN, Victor M et al. Link of a ubiquitous human coronavirus to dromedary camels. In: Proceedings of the National Academy of Sciences of the United States of America, 2016, vol. 113, n° 35, p. 9864–9869. doi: 10.1073/pnas.1604472113.
CONFERENCE PRESENTATIONS
- PAGANO, Sabrina et al. SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1. In: EAS Congress 2021. Virtual Congress. 2021. e78 p. doi: 10.1016/j.atherosclerosis.2021.06.227.